SEC 13F Intelligence

Point72 Asia (Singapore) Pte. Ltd. / ITCIEUR

Point72 Asia (Singapore) Pte. Ltd.’s Intra-Cellular Therapies Inc Position

Does Point72 Asia (Singapore) Pte. Ltd. own Intra-Cellular Therapies Inc (ITCIEUR)? Not currently — the last reported position was 48.7K shares worth $6M in Q1 2025; the fund’s latest 13F (Q3 2025) no longer reports it.

Position Value
$6M
Q1 2025
Shares
48.7K
% of Portfolio
+1.69%
Quarters Held
1
position exited

Position History ITCIEUR

Reported value by quarter
Q1 ’25: $6MQ1 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202548.7K$6M+1.69%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Point72 Asia (Singapore) Pte. Ltd.’s full portfolio or all institutional holders of ITCIEUR.